| UPSA Switzerland AG - Dafalgan, Brausetabletten 500 mg |
| 47503 | | 01 | | Dafalgan, Brausetabletten 500 mg | | | | N02BE01 | | Paracetamol | | 03.12.1986 | | |
|
| Composition |
| paracetamolum 500 mg, acidum citricum, natrii hydrogenocarbonas, natrii carbonas, natrii docusas, povidonum, sorbitolum 300 mg, saccharinum natricum, E 211 60.606 mg pro compresso corresp. natrium 412.3 mg. |
| Packungsbestandteile |
| Active Agent | Dose |
|---|
| Paracetamol | 500 mg |
| | BAG: Active Agent | Dose |
|---|
| Paracetamol | 500 mg |
| | Inactive agents | Dose | additional_information |
|---|
| Citric Acid | | | | E 211 | 60.606 mg | conserv. | | Sodium Carbonate | | | | Natrii Docusas | | | | Sodium Hydrogen Carbonate | | | | Povidone | | | | Pro Compresso | | | | Saccharinum Natricum | | | | Sorbitol | 300 mg | |
| |
|
| Teilbarkeit |
| | Nein | | | | Ja | | | | Ja | | | | -- | | | | | | | | | |
|
|
